NCT04752332
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04752332
Title A Study of Abemaciclib (LY2835219) Plus Hormone Therapy in Participants With Early Breast Cancer (eMonarcHER)
Acronym eMonarcHER
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors Eli Lilly and Company
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | ITA | ISR | HUN | GRC | GBR | FRA | ESP | DEU | CHE | BRA | BEL | AUT | AUS | ARG

*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field